Literature DB >> 29625023

Identification of Misclassified ClinVar Variants via Disease Population Prevalence.

Naisha Shah1, Ying-Chen Claire Hou1, Hung-Chun Yu1, Rachana Sainger1, C Thomas Caskey2, J Craig Venter3, Amalio Telenti4.   

Abstract

There is a significant interest in the standardized classification of human genetic variants. We used whole-genome sequence data from 10,495 unrelated individuals to contrast population frequency of pathogenic variants to the expected population prevalence of the disease. Analyses included the ACMG-recommended 59 gene-condition sets for incidental findings and 463 genes associated with 265 OrphaNet conditions. A total of 25,505 variants were used to identify patterns of inflation (i.e., excess genetic risk and misclassification). Inflation increases as the level of evidence supporting the pathogenic nature of the variant decreases. We observed up to 11.5% of genetic disorders with inflation in pathogenic variant sets and up to 92.3% for the variant set with conflicting interpretations. This improved to 7.7% and 57.7%, respectively, after filtering for disease-specific allele frequency. The patterns of inflation were replicated using public data from more than 138,000 genomes. The burden of rare variants was a main contributing factor of the observed inflation, indicating collective misclassified rare variants. We also analyzed the dynamics of re-classification of variant pathogenicity in ClinVar over time, which indicates progressive improvement in variant classification. The study shows that databases include a significant proportion of wrongly ascertained variants; however, it underscores the critical role of ClinVar to contrast claims and foster validation across submitters.
Copyright © 2018 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACMG; ClinVar; OrphaNet; pathogenic variant; penetrance; prevalence

Mesh:

Year:  2018        PMID: 29625023      PMCID: PMC5985337          DOI: 10.1016/j.ajhg.2018.02.019

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  43 in total

Review 1.  Variations of type IV collagen-encoding genes in patients with histological diagnosis of focal segmental glomerulosclerosis.

Authors:  Erol Demir; Yasar Caliskan
Journal:  Pediatr Nephrol       Date:  2019-06-28       Impact factor: 3.714

Review 2.  Settling the score: variant prioritization and Mendelian disease.

Authors:  Karen Eilbeck; Aaron Quinlan; Mark Yandell
Journal:  Nat Rev Genet       Date:  2017-08-14       Impact factor: 53.242

3.  Using High-Resolution Variant Frequencies Empowers Clinical Genome Interpretation and Enables Investigation of Genetic Architecture.

Authors:  Nicola Whiffin; Angharad M Roberts; Eric Minikel; Zach Zappala; Roddy Walsh; Anne H O'Donnell-Luria; Konrad J Karczewski; Steven M Harrison; Kate L Thomson; Helen Sage; Alexander Y Ing; Paul J R Barton; Birgit Funke; Stuart A Cook; Daniel G MacArthur; James S Ware
Journal:  Am J Hum Genet       Date:  2019-01-03       Impact factor: 11.025

4.  Clinical Genetic Screening in Adult Patients with Kidney Disease.

Authors:  Enrico Cocchi; Jordan Gabriela Nestor; Ali G Gharavi
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-09       Impact factor: 8.237

5.  Clinical Cardiovascular Genetic Counselors Take a Leading Role in Team-based Variant Classification.

Authors:  Chloe Reuter; Megan E Grove; Kate Orland; Katherine Spoonamore; Colleen Caleshu
Journal:  J Genet Couns       Date:  2017-12-12       Impact factor: 2.537

6.  PGG.SNV: understanding the evolutionary and medical implications of human single nucleotide variations in diverse populations.

Authors:  Chao Zhang; Yang Gao; Zhilin Ning; Yan Lu; Xiaoxi Zhang; Jiaojiao Liu; Bo Xie; Zhe Xue; Xiaoji Wang; Kai Yuan; Xueling Ge; Yuwen Pan; Chang Liu; Lei Tian; Yuchen Wang; Dongsheng Lu; Boon-Peng Hoh; Shuhua Xu
Journal:  Genome Biol       Date:  2019-10-22       Impact factor: 13.583

7.  Understanding the genetic architecture of human retinal degenerations.

Authors:  J Fielding Hejtmancik; Stephen P Daiger
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-07       Impact factor: 11.205

8.  A mutation map for human glycoside hydrolase genes.

Authors:  Lars Hansen; Diab M Husein; Birthe Gericke; Torben Hansen; Oluf Pedersen; Mitali A Tambe; Hudson H Freeze; Hassan Y Naim; Bernard Henrissat; Hans H Wandall; Henrik Clausen; Eric P Bennett
Journal:  Glycobiology       Date:  2020-07-16       Impact factor: 4.313

Review 9.  Genetic testing for kidney disease of unknown etiology.

Authors:  Thomas Hays; Emily E Groopman; Ali G Gharavi
Journal:  Kidney Int       Date:  2020-04-24       Impact factor: 10.612

10.  Variable population prevalence estimates of germline TP53 variants: A gnomAD-based analysis.

Authors:  Kelvin C de Andrade; Megan N Frone; Talia Wegman-Ostrosky; Payal P Khincha; Jung Kim; Amina Amadou; Karina M Santiago; Fernanda P Fortes; Nathanaël Lemonnier; Lisa Mirabello; Douglas R Stewart; Pierre Hainaut; Luiz P Kowalski; Sharon A Savage; Maria I Achatz
Journal:  Hum Mutat       Date:  2018-11-19       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.